何淼红 徐吉芬
【摘要】 目的:觀察奥扎格雷钠联合桂哌齐特治疗动脉硬化性脑梗死(arteriosclerotic cerebral infarction,ACI)患者的临床效果以及对血液流变学、血脂的影响。方法:选取2015年6月-2016年1月本院收治的动脉硬化性脑梗死患者120例,按照随机数字表法将其分为观察组和对照组,各60例。对照组给予桂哌齐特治疗,观察组采用桂哌齐特联合奥扎格雷钠治疗。两组均14 d为一疗程,共治疗两个疗程。比较两组治疗前后血液流变学指标以及血脂情况;观察两组治疗1个月后的临床疗效;通过对患者进行为期1年的随访,观察随访期间两组患者的不良反应发生情况。结果:治疗后,两组HDL水平均高于治疗前,TG、TC、LDL水平及血液流变学指标均低于治疗前,比较差异均有统计学意义(P<0.05),且观察组HDL水平高于对照组,TG、TC、LDL水平及血液流变学指标均低于对照组,比较差异均有统计学意义(P<0.05)。观察组总有效率为85.0%,高于对照组的66.7%(P<0.05),两组均未见严重的不良反应。结论:奥扎格雷钠联合桂哌齐特治疗ACI可改善患者的血液流变学及血脂水平,效果良好,值得临床推广应用。
【关键词】 桂哌齐特; 奥扎格雷钠; 脑梗死; 血液流变学; 血脂
Clinical Effect of Cinepazide Combined with Ozagrel Sodium in Treatment of Atherosclerotic Cerebral Infarction and Its Effect on Hemorheology and Blood Lipid/HE Miaohong,XU Jifen.//Medical Innovation of China,2018,15(01):059-062
【Abstract】 Objective:To observe the clinical effect of Cinepazide combined with Ozagrel Sodium in treatment of arteriosclerotic cerebral infarction(ACI) and its effect on hemorheology and blood lipid.Method:A total of 120 patients with ACI admitted to our hospital from June 2015 to January 2016 were selected,according to random number table,they were divided into observation group and control group,60 cases in each group.The control group was given Cinepazide,and observation group were treated with Cinepazide combined with Sodium Ozagrel.They were treated with 14 days as a course of treatment,a total of two courses of treatment.The hemorheology indexes and blood lipid were compared between two groups before and after treatment,the clinical curative effect of two groups after treatment 1 month was observed,the patients were followed up for 1 year,and the adverse reactions of two groups were observed during the follow-up period.Result:After treatment,the levels of HDL in two groups were all higher than those of before treatment,the levels of TG,TC,LDL and hemorheology indexes were all lower than those of before treatment,the differences were statistically significant(P<0.05),and the levels of HDL in observation group was higher than that of control group,the levels of TG,TC,LDL and hemorheology indexes were all lower than those of control group,the differences were statistically significant(P<0.05).The total effective rate of observation group was 85.0%,which was higher than 66.7% of control group(P<0.05),and no serious adverse reactions were found in the two groups.Conclusion:Sodium Ozagrel combined with Cinepazide in treating ACI can improve hemorheology and blood lipid level,the effect is good,and is worthy of clinical application.endprint
【Key words】 Cinepazide; Ozagrel Sodium; Cerebral infarction; Hemorheology; Blood lipid
First-authors address:Guangzhou Huadu District Peoples Hospital,Guangzhou 510800,China
doi:10.3969/j.issn.1674-4985.2018.01.016
随着生活水平的提高以及人口老龄化进程的加速,脑血管疾病的发病率越来越高,已成为我国导致人类死亡的三大主要疾病之一。而动脉硬化性脑梗死(arteriosclerotic cerebral infarction,ACI)作为脑血管疾病中一种常见的脑部病变,该疾病是脑血管硬化后,由于脑组织局部动脉血流减少,造成脑组织供血供氧不足引起的一种病变,严重影响患者的生活质量。目前,临床上对于该疾病的治疗主要以药物治疗为主,但治疗效果仍不理想,患者的预后较差。本文选取ACI患者120例进行用药研究,所用药物为奥扎格雷钠、桂哌齐特,通过分析这两种药物对于ACI患者的影响,以期为ACI临床治疗提供理论参考依据。……